GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Interest Expense

Albert Labs International (XCNQ:ABRT) Interest Expense : C$0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Albert Labs International's interest expense for the three months ended in Sep. 2023 was C$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Albert Labs International's Operating Income for the three months ended in Sep. 2023 was C$ -0.02 Mil. Albert Labs International's Interest Expense for the three months ended in Sep. 2023 was C$ 0.00 Mil. GuruFocus does not calculate Albert Labs International's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Albert Labs International Interest Expense Historical Data

The historical data trend for Albert Labs International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Interest Expense Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Interest Expense
- -

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Albert Labs International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International  (XCNQ:ABRT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Albert Labs International's Interest Expense for the three months ended in Sep. 2023 was C$0.00 Mil. Its Operating Income for the three months ended in Sep. 2023 was C$-0.02 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was C$0.01 Mil.

Albert Labs International's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

GuruFocus does not calculate Albert Labs International's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines